STAR Pharmaceutical Limited. provides financial guidance for the fourth quarter and full year ended December 31, 2011. For the full year, the company deems it appropriate to issue a profit warning in respect of the financial results of the company and its subsidiaries for fourth quarter of 2011. Based on preliminary financial figures, the Group's fourth quarter of 2011 results might be adversely affected mainly due to ongoing volume and selling price controls for certain products by the China government, and losses incurred by the Group's Traditional Chinese Medicine Research and Development segment. The Group expects to report a loss for fourth quarter of 2011 as a result of the above.